NEW YORK, Jan. 09, 2017 -- Progyny, a leading reproductive health technology and services company, today announced the appointment of former WebMD CFO, Peter Anevski, as its Chief Financial Officer and Chief Operating Officer. He joins newly appointed Chief Executive Officer, David Schlanger, and President of Health Services, Karin Ajmani, on Progyny’s management team.
“I’m delighted to become a part of Progyny and resume my longstanding working relationship with CEO, David Schlanger. It’s an exciting time to be at the company as it charts the next phase of growth in developing unique science-based and data-driven reproductive technology and in penetrating the employer market for fertility benefits,” said Anevski.
Commenting on Anevski’s appointment, Schlanger commented: “Pete brings over 17 years of experience in the healthcare industry at WebMD where he and I worked together to deliver record revenues and profits and substantial share price appreciation during the more than three years that we led the company. Progyny is now in a position where it needs the financial and operations skills of someone like Pete. He will be a critical member of the management team that will take Progyny forward to capitalize on the significant opportunity in the global fertility services market.”
About Peter Anevski
Pete joined WebMD in 1999 and served as senior management in a number of finance and operations roles, becoming the company's CFO in 2013. He played an integral role in WebMD’s growth in revenue and profitability through implementation of changes in pricing and market positioning, programmatic strategy and execution and other finance and operating disciplines that led to the company's improved financial performance. Prior to joining WebMD, Pete was in corporate accounting at Toys "R" Us and a CPA with Wiss &Co, LLP.
ABOUT PROGYNY
Progyny is a leading reproductive health technology and services company that combines data, science and technology to provide the first end-to-end, proactive fertility solution for self-insured employers to offer as a benefit to employees.
Progyny’s SMART Cycle™ plan design improves outcomes, shortens time to pregnancy and reduces total fertility-related costs. Progyny is privately held and is headquartered in New York, NY, with operations in San Francisco, CA. Please visit www.progyny.com.
Media Contact: Selena Yang [email protected]


Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 



